# Sulfasalazine and Endothelial Function

> **NCT00554203** · NA · COMPLETED · sponsor: **Boston University** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Sulfasalazine

## Key facts

- **NCT ID:** NCT00554203
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554203, "Sulfasalazine and Endothelial Function". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00554203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*